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Aldosterone enhances renal calcium reabsorption
by two types of channels
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Aldosterone enhances renal calcium reabsorption by two types
of channels.
Background. Aldosterone has been known for many years
to increase sodium (Na+) reabsorption by the distal nephron.
The present in vitro experiments investigated the effect of the
hormone on calcium (Ca2+) transport by the luminal membrane
of the rabbit nephron, independent of any systemic influence.
Methods. Proximal and distal tubules were incubated with
either aldosterone or the carrier. The luminal membranes of
these tubules were purified, vesiculated, and 45Ca uptake by
these vesicles was subsequently measured.
Results. Treatment of the distal tubules with 10−8 mol/L al-
dosterone enhanced both 0.1 and 0.5 mmol/L Ca2+ transport.
The hormone action was abolished by tyrosine kinase inhibitors.
The presence of Na+ in the medium decreased both Ca2+ up-
take and the effect of aldosterone. This hormone action was
already significant after a 5-minute incubation, with a half-
maximal efficient concentration of approximately 10−10 mol/L.
Ca2+ transport by the distal membranes presents a dual kinetics.
Aldosterone enhanced the Vmax values of both components of
these kinetics. Mibefradil abolished the action of aldosterone on
0.5 mmol/L but not on 0.1 mmol/L Ca2+ uptake, suggesting that
the targeted low affinity channel belongs to the T-type, whereas
diltiazem prevented the hormone action exclusively at the low
Ca2+ concentration (0.1 mmol/L), indicating an effect on a high
affinity L-type channel.
Conclusion. Aldosterone increases Ca2+ transport by the dis-
tal luminal membranes through L- and T-type Ca2+ channels,
and this action requires tyrosine kinase activity.
It has been known for several decades that
mineralocorticoid-depleted patients have a tendency to
present hyponatremia, acidosis, and volume contrac-
tion, while mineralocorticoid excess provokes opposite
metabolic abnormalities [1].
A number of experiments using several techniques
showed that aldosterone has a highly significant effect on
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transepithelial potential difference in the late segments
of the nephron, reflecting a stimulation of the amiloride-
sensitive Na+ transport by the apical membranes.
In contrast to the abundant literature dealing with the
antinatriuretic effect of aldosterone, data concerning its
action on Ca2+ transport are relatively scarce. Clearance
studies showed either an increase in calciuria [2] or an
absence of significant change of Ca2+ excretion [3, 4] af-
ter aldosterone administration. In a randomized study in
male volunteers, Van Hamersvelt et al [5] compared the
effect of the Ca2+ channel blocker felodipine, alone or
in association with aldosterone. Felodipine alone had a
natriuretic effect, which was attenuated by aldosterone.
The action of felodipine was attributed to the proximal
tubule. However, in this study, calciuria was not mea-
sured. Resnick et al [6] reported the cases of seven hyper-
tensive patients with primary aldosteronism whose serum
Ca2+ rose significantly after removal of the aldosterone-
producing tumor. This rise was thought to be the result
of a secondary hyperparathyroidism, rather than a direct
effect of aldosterone suppression on Ca2+ reaborption.
Finally, Kabadi [7] observed a patient with primary hyper-
aldosteronism and renal calculi who presented a decline
in the excretion of Ca2+ and uric acid after spironolactone
administration. The author concluded that aldosterone
decreases Ca2+ reabsorption.
The purpose of the present study was to investigate the
effect of aldosterone on Ca2+ transport by the nephron,
independent of any systemic changes and independent of
the antinatriuretic action. The hormone did not influence
electrolyte transport by the proximal membranes. In con-
trast and unexpectedly, treatment of rabbit distal tubules
with aldosterone enhanced both Na+ and Ca2+ uptake
by the corresponding luminal membranes.
METHODS
Tubule preparation
Fresh rabbit kidneys were directly obtained from
the slaughterhouse. The rabbit strains were heteroge-
neous (New Zealand, Satin, Chinchilla, and California)
equally males and females, 9 to 13 weeks old. The renal
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cortical tissue was minced and first digested for 5 min-
utes at 35◦C in HAMF-12 culture medium equilibrated
with 95% O2, and containing 1 mg/mL collagenase type
V clostridium histolyticum with 5 mg/mL bovine serum
albumin (BSA). The tissue was rinsed with the culture
medium in a tea strainer and again digested for 20 min-
utes at 35◦C in the same medium containing collagenase,
BSA, and 10,000 U/mL DNAse. This new suspension was
filtered, and the filtrate was centrifuged for 20 seconds
in a table centrifuge. The collected tubules were rinsed
with Krebs-Henseleit buffer (KHB) and BSA, and fi-
nally suspended in the culture medium containing 45%
Percoll equilibrated with 95% O2. After centrifugation
for 30 minutes at 28,000g, the distal and proximal tubule
enriched bands were collected separately and washed
in KHB with BSA to remove the Percoll. The distal
tubule suspensions, visualized under the microscope, con-
tained a mixture of distal convoluted tubules, connecting
tubules, and cortical collecting ducts.
Incubation of the tubules with aldosterone
The tubules were incubated with aldosterone or the
carrier in HAMF-12 at 35◦C for 5 minutes unless other-
wise specified. Incubation was stopped by rapid dilution
in ice-cold KHB/BSA. The tubules were washed twice
in this solution, and an additional time with KHB with-
out BSA, and then were frozen in 10 mmol/L mannitol,
20 mmol/L Tris-HEPES (pH 7.4) at −80◦C.
Luminal membrane purification
On the day of the experiment, the frozen proximal and
distal tubules were thawed and homogenized, and the
luminal membranes purified using the MgCl2 precipita-
tion technique: 12 mmol/L MgCl2 (final concentration)
was added to the suspension, which was stirred on ice
for 20 minutes (proximal tubules) or 10 minutes (distal
tubules) and centrifuged at 3000g for 20 minutes. The su-
pernatants were collected and centrifuged at 28,000g for
20 minutes at 4◦C. The membrane pellets were suspended
in 280 mmol/L mannitol with 20 mmol/L Tris-HEPES
(pH 7.4), and allowed to vesiculate at 4◦C for one hour.
Calcium and sodium transport measurement
45Ca and 22Na uptakes by the vesicles were measured
by the rapid Millipore filtration technique. Uptakes were
initiated by adding 25 lL of incubation medium at 35◦C
to 5 lL of membrane suspension (approximately 25 lg
protein). In Ca2+ transport experiments, the incubation
medium contained, in addition to the 45CaCl2 at the indi-
cated concentration, 20 mmol/L Tris-HEPES (pH 7.4)
with either 120 mmol/L NaCl and 20 mmol/L choline
chloride or 140 mmol/L choline chloride. Each uptake
was stopped by addition of 1 mL of 150 mmol/L KCl,
20 mmol/L Tris-HEPES (pH 7.4), and 2 mmol/L EGTA,
Table 1. Enzyme activities in the membrane preparations
Alkaline phosphatase Na-K ATPase
Preparation nmol/lg/15 min nmol/lg/20 min
Cortex 2.65 ± 0.24 3.40 ± 0.34
PT homogenates 2.66 ± 0.32 2.98 ± 0.34
Luminal membranes 14.59 ± 2.01 (×5.48) 2.05 ± 0.27 (×0.68)
Cortex 1.82 ± 0.17 1.70 ± 0.11
DT homogenates 0.40 ± 0.04 (×0.19) 1.09 ± 0.17 (×0.64)
DT LUM membranes 1.39 ± 0.10 (×0.76) 0.92 ± 0.09 (×0.54)
Data are mean values ± SEM, N = 12.
and the suspension rapidly filtered through Millipore
filters. In 22Na transport experiments, the incubation
medium contained 278 mmol/L mannitol, 20 mmol/L Tris-
HEPES (pH 7.4) and 1 mmol/L 22NaCl, and the uptake
was stopped by 1 mL of a solution containing 140 mmol/L
LiCl2 and 20 mmol/L Tris-HEPES (pH 7.4). In each ex-
periment, the nonspecific binding was measured at time
0 of incubation and substracted from the total uptake.
Enzyme marker measurements
The purity of the tubule suspensions and membranes
was monitored by measurement of the specific enzyme
markers (Table 1). Alkaline phosphatase (the proximal
tubule luminal membrane specific enzyme) activity was
determined according to the technique of Kelly and
Hamilton [8], and Na-K-ATPase (the basolateral mem-
brane marker) by the technique of Post and Sen [9]. Pre-
vious experiments performed with membranes prepared
in same manner showed very low activities of succinate-
dehydrogenase and glucose-phosphatase, indicating neg-
ligible contamination with mitochondrial or endoplasmic
reticulum membranes [10].
Statistics and calculation
All of the uptake measurements were carried out in
duplicate, and the figures reflect the mean values ± SEM
of three to six experiments as indicated. The results were
analyzed by the Student unpaired t test. The kinetic values
of Ca2+ uptake were calculated according to the nonlin-
ear regression analysis of Huntson [11]. Passive diffusion
was evaluated by the slope of Ca2+ transport at saturating
concentrations.
Materials
45CaCl2 (carrier free) was obtained from Perkin-Elmer
Life Science (Boston, MA, USA). Aldosterone, can-
renone, spironolactone, cycloheximide, collagenase V,
and other chemicals were obtained from Sigma Aldrich
Company (St. Louis, MO, USA). x-Conotoxin MVIIC
was purchased from Calbiochem (San Diego, CA, USA),
the filters from Millipore Co. (Bedford, MA, USA), and
Mibefradil was kindly provided by Hoffman Laroche Co.
(Basel, Switzerland).
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Fig. 1. Effect of 10−8 mol/L aldosterone on 0.5 mmol/L Ca2+ uptake
by the distal luminal membrane in the presence (N = 3) and absence
(N = 5) of 100 mmol/L Na+. ∗P < 0.05, ∗∗P < 0.01 compared with the
control values from untreated tubules, unpaired t test.
RESULTS
Effect of aldosterone on Ca2+ uptake by the proximal
and distal luminal membranes
Probably caused by an absence [12], or a low level
[13] of receptors, incubation of proximal tubules with al-
dosterone did not influence Ca2+ uptake by the corre-
sponding luminal membrane vesicles: 0.5 mmol/L Ca2+
transports were 0.51 ± 0.05 and 0.49 ± 0.04 pmol/lg/10
seconds in control and experimental conditions (N = 3).
The effect of 10−8 mol/L aldosterone on Ca2+ uptake
by the distal luminal membranes is depicted in Figure 1.
Because of the inhibitory action of Na+ upon Ca2+ trans-
port, the experiments were performed in the absence and
in the presence of 100 mmol/L NaCl. In the absence of
Na+, treatment of tubules with 10−8 mol/L aldosterone
enhanced 0.5 mmol/L Ca2+ by the distal membranes from
0.56 ± 0.04 to 0.74 ± 0.06 pmol/lg/10 seconds, P < 0.05,
unpaired t test, N = 6. In the presence of 100 mmol/L
Na+, however, the effect of the hormone was no longer
evident (0.46 ± 0.02 vs. 0.44 ± 0.02 pmol/lg/10 seconds,
NS).
Effect of aldosterone on Na+ uptake
by the distal membranes
Confirming the well-documented action of aldosterone
on Na+ reabsorption by the distal tubule, incubation of
tubules with 10−8 mol/L aldosterone enhanced 1 mmol/L
Na+ uptake in the absence of Ca2+ in the medium, from
0.60 ± 0.02 to 0.98 ± 0.04 pmol/lg/10 seconds (P < 0.01,
N = 4). In the presence of 2.0 mmol/L Ca2+, Na+ up-
take decreased but still remained sensitive to aldosterone
(0.34 ± 0.01 and 0.60 ± 0.03 pmol/lg/10 seconds in con-
trol and experimental conditions, respectively, P < 0.01,
N = 3).
Variation of Ca2+ and Na+ uptakes
with the time of tubule incubation
Interestingly, the effect of the hormone on the trans-
port of both cations was extremely rapid, as are most
of the hormonal actions on the distal nephron. Figure 2
presents the variation of 0.5 mmol/L Ca2+ and 1.0 mmol/L
Na+ uptakes with the time of tubule incubation. Indeed, a
5-minute incubation was sufficient to enhance both Ca2+
and Na+ transports. Although not statistically signifi-
cant for Ca2+ uptake, a stimulatory tendency was already
detectable after a 1-minute incubation. However, after
15 minutes, the effect on Ca2+ uptake disappeared,
whereas that on Na+ remained slightly more stable.
The dose-response curve
To determine the efficient concentrations of aldos-
terone on Ca2+ and Na+ uptakes, the distal tubules were
incubated for 5 minutes with hormone concentrations
varying from 0 to 10−6 mol/L. As shown in Figure 3, the
peak action was obtained at 10−8 mol/L and above, with
a half-maximal efficient concentration of 10−10 mol/L.
These concentrations are close to the physiologic values
in human plasma (1 to 8 × 10−9 mol/L in our hospital
institution).
The action of aldosterone on the kinetic parameters
of Ca2+ uptake
We repeatedly observed a dual kinetics of Ca2+ trans-
port by the distal luminal membranes, an observation
which corroborates the finding of at least two Ca2+ chan-
nels reported by Barry et al [14] using molecular cloning
and antisense techniques, Suzuki et al [15] using electro-
physiology techniques, Peng et al [16, 17], who expressed
the two channels in Xenopus laevis oocytes, and Ohki G
et al [abstract; J Am Soc Nephrol 12:757A, 2001], who
characterized ECaC2 mRNA in the mouse kidney. Un-
expectedly, incubation of distal tubules with 10−8 mol/L
aldosterone for 5 minutes increased Vmax values of both
kinetics, from 0.42 ± 0.03 to 0.57 ± 0.06 (P < 0.02), and
from 1.27 ± 0.19 to 2.03 ± 0.30 pmol/lg/10 seconds (P <
0.02, N = 6) for the high and the low affinity components,
respectively (Fig. 4 and Table 2).
Interference of Na+ upon the effect of aldosterone
on Ca2+ transport
We have seen in Figure 1 that in the presence of
100 mmol/L Na+, 10−8 mol/L aldosterone does not en-
hance any more 0.5 mmol/L Ca2+ uptake by the distal
luminal membranes. To further investigate this inhibitory
effect of Na+, the stimulation of Ca2+ uptake by the hor-
mone was measured in the presence of increasing con-
centrations of Na+. As expected, Na+ decreased Ca2+
uptake, and the effect of aldosterone on this transport
progressively disappeared (Fig. 5).
The messengers involved in the action of aldosterone
on Ca2+ uptake
To clarify the mechanism of the hormone action, a
new series of experiments was performed using various
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Fig. 2. Effect of 10−8 mol/L aldosterone on
1 mmol/L Na+ and 0.5 mmol/L Ca2+ up-
take by the distal luminal membrane: varia-
tion with time of tubule incubation. ∗P < 0.05,
∗∗P < 0.02, ∗∗∗P < 0.01 compared with the
control values, unpaired t test, N = 3.
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Fig. 3. Effect of 10−8 mol/L aldosterone on
1 mmol/L Na+ and 0.5 mmol/L Ca2+ up-
takes by the distal luminal membrane: dose-
response curves. ∗P < 0.05, ∗∗P < 0.02, ∗∗∗P <
0.01 compared with the control values from
untreated tubules, unpaired t test, N = 3.
messenger inhibitors: Rp cAMP (anti-cyclicAMP),
calphostin C (anti-protein kinase C), SB 203580 (an anti-
MAP kinase), and two anti-tyrosine kinases, AG 18 and
genistein. Neither Rp cAMP nor calphostin C nor SB
203580 prevented the aldosterone-dependent increase in
Ca2+ uptake: 0.5 mmol/L Ca2+ uptake increased from
0.51 ± 0.02 to 0.87 ± 0.075 (P < 0.01) and from 0.53 ±
0.015 to 0.92 ± 0.01 pmol/ug/10 seconds (P < 0.02) in
the absence and presence of 10−4 mol/L Rp cAMP, from
0.57 ± 0.15 to 0.84 ± 0.18 and 0.62 ± 0.12 to 0.94 ±
0.24 (P < 0.05) pmol/ug/10 seconds in the absence and
presence of 10−6 mol/L calphostin C, and from 0.58 ±
0.01 to 0.89 ± 0.10 (P < 0.05) and 0.63 ± 0.02 to 0.88 ±
0.06 pmol/ug/10 seconds (P < 0.01) in the absence and
presence of SB 203580. In contrast, the two tyrosine ki-
nase inhibitors completely abolished the effect of aldos-
terone on 0.5 mmol/L Ca2+ transport (Fig. 6, Table 3)
Effect of spironolactone and canrenone on the
aldosterone dependent Ca2+ uptake
In vivo, spironolactone is utilized as an aldosterone an-
tagonist at the hormone receptors of the epithelial cells
of the kidney, and therefore is used in the treatment
of hyperaldosteronism. Preliminary experiments failed
to demonstrate any effect of 10−6 mol/L spironolactone
on Ca2+ uptake by the distal luminal membranes; how-
ever, in vivo, spironolactone is metabolized mainly by the
liver to active metabolites, among which is canrenoic acid.
Therefore, tubules were incubated with either 10−6 mol/L
canrenone alone, 10−8 mol/L aldosterone alone, or aldos-
terone and canrenone. Then, 0.1 and 0.5 mmol/L Ca2+
uptakes by the corresponding luminal membrane vesi-
cles were measured. Canrenone did not inhibit the effect
of aldosterone, neither on 0.1 mmol/L Ca2+ (0.39 ± 0.03
vs. 0.40 ± 0.03 pmol/lg/10 seconds) nor on 0.5 mmol/L
Ca2+ transports (0.84 ± 0.05 vs. 0.85 ± 0.01 pmol/lg/10
seconds, N = 3).
Effect of protein synthesis inhibition
on the aldosterone action
Also suggesting a nongenomic mechanism implicated
in the aldosterone action on Ca2+ uptake was the lack
of influence of protein synthesis inhibition. In a new se-
ries of experiments, distal tubules were incubated with
246 Leclerc et al: Aldosterone enhances calcium reabsorption by two channels
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
V,
 
pm
ol
/µ
g/
10
s
0 2 4 6 8 10 12 14
V/S, mmol/L
Control
Aldosterone
Fig. 4. Effect of 10−8 mol/L aldosterone on the Eadie-Hofstee plot of
Ca2+ uptake by the distal luminal membrane, N = 3.
Table 2. Effect of 10−8 mol/L aldosterone on Ca2+ uptake by distal
luminal membranes: Kinetics parameters
Component Affinity Control Aldosterone
Km mmol/L Low 1.20 ± 0.19 1.79 ± 0.62
High 0.052 ± 0.007 0.041 ± 0.006
Vmax pmol/lg/10s Low 1.27 ± 0.19 2.03 ± 0.30a
High 0.42 ± 0.032 0.57 ± 0.06a
aP < 0.02 compared with control values, N = 6.
10−8 mol/L aldosterone in the presence and the absence
of 10−6 mol/L cycloheximide. The inhibitor did not in-
terfere with the hormone effect: 0.5 mmol/L Ca2+ up-
takes increased from 0.51 ± 0.03 to 0.85 ± 0.06 and from
0.53 ± 0.04 to 0.85 ± 0.05 pmol/lg/10 seconds (P < 0.01,
N = 3) by membranes from control and treated tubules
in the absence and presence of the inhibitor.
What types of Ca2+ channels are influenced
by aldosterone?
According to the Eadie-Hofstee plot presented above,
aldosterone enhanced Ca2+ uptake by both the low and
high affinity channels. To further characterize these chan-
nels, we studied the effects of various antagonists on
vesicles prepared from control and aldosterone treated
tubules: mibefradil, a T-type antagonist, diltiazem, a L-
type antagonist, and x-conotoxin MVIIC, a P/Q type an-
tagonist. Distal tubules were incubated with 10−8 mol/L
aldosterone or with the carrier for 5 minutes at 35◦C.
Then, luminal membranes were purified, and 0.1 or
0.5 mmol/L Ca2+ uptakes by these membranes were
measured both in the presence and absence of each in-
hibitor. In membranes from untreated tubules, 1 lmol/L
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Fig. 6. Effect of two tyrosine-kinase inhibitors: 5 × 10−5 mol/L AG 18
and 10−6 mol/L genistein on 0.5 mmol/L Ca2+ uptake by membranes
from distal tubules treated with 10−8 mol/L aldosterone, N = 3.
mibefradil had no influence on either 0.1 or 0.5 mmol/L
Ca2+ transport, 50 lmol/L diltiazem slightly decreased
0.1 mmol/L Ca2+ uptake from 0.42 ± 0.03 to 0.33 ±
0.04 pmol/lg/10 seconds (P < 0.05, N = 3, paired t test)
without affecting the 0.5 mmol/L Ca2+ transport (0.64 ±
0.03 and 0.61 ± 0.03 pmol/lg/10 seconds, NS), while
100 nmol/L x-conotoxin MVIIC decreased 0.5 mmol/L
Ca2+ uptake from 0.63 ± 0.01 to 0.47 ± 0.05 pmol/lg/10
seconds (P < 0.02, N = 5) without influencing the
0.1 mmol/L Ca2+ transport (0.32 ± 0.03 and 0.33 ±
0.04 pmol/lg/10 seconds, NS). In contrast to these modest
effects on membranes from untreated tubules, mibefradil
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Table 3. Effect of tyrosine kinase inhibition on the aldosterone
sensitive 0.5 mmol/L Ca2+ uptake (pmol/lg/10s)
Control 0.59 ± 0.05 Control 0.55 ± 0.05
Aldosterone 0.84 ± 0.24a Aldosterone 0.80 ± 0.01a
AG 18 0.59 ± 0.32 Genistein 0.53 ± 0.07
Aldo + AG 18 0.65 ± 0.02 Aldo + Genistein 0.59 ± 0.03
aP < 0.01 compared with the control values, N = 3.
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Fig. 7. Effect of 1 lmol/L mibefradil, 50 lmol/L diltiazem, or 100
nmol/L x-conotoxin MVIIC on 0.1 or 0.5 mmol/L Ca2+ uptake by
membranes from control or aldosterone treated distal tubules. ∗P <
0.05, ∗∗P < 0.02, ∗∗∗P < 0.01 compared with the control values from un-
treated membranes, paired t test; P < 0.05 and P < 0.02 compared
with the values obtained with untreated membranes, but from tubules
incubated with aldosterone, N = 4.
and diltiazem strongly diminished the Ca2+ transport
response to the hormone, and again, their inhibitory
effects depended upon Ca2+ concentration. As repro-
ducibly observed, 10−8 mol/L aldosterone enhanced both
0.1 mmol/L and 0.5 mmol/L Ca2+ uptakes. Diltiazem
(50 lmol/L) completely abolished the effect of aldos-
terone on 0.1 mmol/L, but not on 0.5 mmol/L Ca2+
transport, whereas 1 lmol/L mibefradil prevented the
hormone influence on 0.5 mmol/L but not on 0.1 mmol/L
Ca2+ uptake. Finally, 100 nmol/L x-conotoxin MVIIC
failed to modify the response to 10−8 mol/L aldosterone
at any of the two concentrations of Ca2+ (Fig. 7).
These results suggest that aldosterone activates two dif-
ferent types of Ca2+ channels, the diltiazem-sensitive L-
type, and the mibefradil-sensitive T-type. The P/Q type,
which has also been described in the distal membrane,
and which is sensitive to x-conotoxin MVIIC [abstract;
Brunette MG et al, J Am Soc Nephrol, 13:281A, 2002],
does not appear to respond to aldosterone.
An attempt to detect a direct action of aldosterone
on membrane vesicles
Ca2+ transport by the luminal membrane of the distal
nephron can be influenced by hormones, according to a
direct mechanism. For instance, it has been shown that
the addition of progesterone to the vesicle suspensions
significantly enhances Ca2+ uptake by these membranes
[18]. In an attempt to search for such a mechanism in
our membrane preparations, aldosterone at concentra-
tions varying from 10−6 to 10−10 mol/L was added to the
vesicle suspensions, and the 10-second 0.5 mmol/L Ca2+
uptake was measured. None of the hormone concentra-
tions tested influenced Ca2+ transport.
DISCUSSION
Aldosterone, a hormone that enhances both Na+ and
Ca2+ transports by the distal tubules: An exception
As mentioned above, for several decades now, aldos-
terone has been known to increase Na+ transport, and
therefore, short-circuit current, through toad bladder
cells, A6 cells, rat distal tubules, or microperfused rat and
rabbit collecting ducts. Therefore, our data confirm this
well-documented action on Na+ channels. However, al-
dosterone also enhances Ca2+ reabsorption by the distal
nephron. This was an unexpected finding because most of
the Ca2+ regulating hormones, such as parathyroid hor-
mone [19, 20], calcitonin [21, 22], calbindin 28K [23], and
angiotensin II [24] act on the two cation transports in op-
posite directions. Several hypotheses could explain this
unusual hormonal effect: aldosterone may target a non-
specific cation channel permeable to both Na+ and Ca2+,
and therefore, different from those which are sensitive
to the hormones cited above. Alternatively, aldosterone
may open separately the Na+ and Ca2+ channels, situated
either in the same or in different distal segments.
The fact that Na+ interferes with the hormone action
on Ca2+ uptake does not argue against an in vivo action.
248 Leclerc et al: Aldosterone enhances calcium reabsorption by two channels
Indeed, Na+ is actively reabsorbed in the ascending limb
of the loop of Henle and the distal tubule, so that in the
distal segments, this electrolyte concentration within the
lumen is relatively low (i.e., around 40 mmol/L) [25].
Aldosterone increases the Vmax of the two Ca2+
uptake kinetics
Recently, Alvarez de la Rosa et al [26] investigated the
effect of aldosterone on the activity of the Na+ channel
ENaC in the A6 cell line. They observed that the hor-
mone induces a fourfold increase in the amount of the
three subunits in the apical membrane, but does not in-
fluence the opening probability. Our observations that
aldosterone increased the Vmax of the two kinetic com-
ponents without affecting the Km values are consistent
with a similar mechanism (i.e., an increase in the number
of active Ca2+ channels, in the absence of any influence
upon the opening probability).
There are several sites of aldosterone receptors
in the distal nephron
Aldosterone-sensitive Na+ channels have been re-
ported in cells of different origins, suggesting that several
segments of the distal nephron contribute to the action
of aldosterone. 3H aldosterone-binding experiments, for
instance, showed multiples sites of receptors. In the rat,
Funder et al [27] observed the presence of such bind-
ings in both the cortex and medulla. In the rabbit, al-
dosterone binding has been precisely described in the
distal convoluted tubule, the connecting, and the collect-
ing tubules [12, 28]. Interestingly, characteristics of these
bindings at the various sites present some variations:
Marver et al [29–31] reported that the cortex and the
outer medulla contain high affinity sites of binding (kD
aldosterone 3 nmol/L), whereas papilla slices present low
affinity sites (kD 28 nmol/L). Farman et al [32] further
characterized these two types of binding: in the cortex,
3H aldosterone bound to the bright (DCTb) and the gran-
ular (DCTg) segments of the distal convoluted tubules,
and was displaced by both aldosterone and dexametha-
sone, whereas in the cortical collecting tubule, only al-
dosterone had this ability. These authors concluded that
variations within these receptor populations were
present. Finally, Todd-Turla et al [13] quantified the levels
of mineralocorticoid and glucocorticoid receptor mRNA
along the nephron. Mineralocorticoid mRNA was partic-
ularly abundant in cortical, outer, and inner medulla col-
lecting duct segments, whereas the glucocorticoid mRNA
was more abundant in the proximal tubules and thick as-
cending limbs. It is therefore probable that the complexity
of the aldosterone action on Ca2+ and Na+ transports by
two Ca2+ channels in the distal nephron is related to the
multiplicity of sites of action.
Neither the presence of spironolactone, nor canrenone,
nor cycloheximide, in the tubule suspension prevented
the effect of aldosterone
In vivo spironolactone plays its aldosterone antagonist
role only after its conversion into canrenone by the liver
[33–35]. Thus, the failure to demonstrate an in vitro in-
hibitory effect of spironolactone is easily explainable by
the absence of such a conversion in our tubule suspen-
sions. However, the addition of canrenone to the tubule
suspension did not prevent the effect of aldosterone ei-
ther. Canrenone targets cytoplasmic steroid receptors,
whose binding to the hormone is a necessary step for a ge-
nomic activity. Also suggesting a nongenomic mechanism
is the lack of influence of cycloheximide, the protein syn-
thesis inhibitor. Therefore, the action of aldosterone ob-
served in the present experiments reflects a nongenomic
mechanism, independent of these cytoplasmic receptors,
and implicating other types of receptors such as those pre-
viously described in various kidney cells or kidney plasma
membranes [36–40].
The role of tyrosine kinase in the action of aldosterone
Our data failed to demonstrate any influence of PKA,
PKC, or P38 MAP kinase on the aldosterone-dependent
Ca2+ uptake. This was an unexpected finding because
a previous study performed in skeletal muscle cell cul-
tures reported a fast transient Ca2+ increase, accompa-
nied by a rise in IP3 content of these cells, reflecting a PKC
stimulation [41]. Instead of such a mechanism, our data
suggests the implication of a tyrosine-kinase. It is there-
fore probable that different messengers are required in
the rapid nongenomic and the slow genomic actions of
the hormone.
Indeed, Gekle et al [42] reported experiments per-
formed in Madin-Darby canine kidney (MDCK) cells,
showing that the nongenomic effect of aldosterone on
Na+/H+ exchanger activity was caused by an activation
of the epidermal growth factor receptor, phosphoryla-
tion of ERK1/2 by a tyrosine-kinase, and subsequently,
opening of Ca2+ channels, Ca2+ influx, and finally, stimu-
lation of Na+/H+ exchanger. Inhibition of the activation
of epidermal growth factor receptor, and then of tyrosine
kinase activity abolished the aldosterone action.
Aldosterone influences L- and T-types of Ca2+ channels
Several sites of action, but also several types of chan-
nels. Indeed, the present data suggest that the hormone
enhances at least two types of Ca2+ channel activity in
the distal luminal membranes. We previously reported
that the low affinity component of Ca2+ uptake by these
membrane is sensitive to calcitonin [22], and the high
affinity component to PTH [20], the vitamin D dependent
calbindin 28K [43], estrogen [44], progesterone [18], and
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angiotensin II [24]. As mentioned above, the presence
of several types of Ca2+ channels has also been reported
in a number of studies using several techniques, among
which are electrophysiology and molecular biology
[14–17].
It is the first time, however, that we have the opportu-
nity to describe a hormone that influences several types
of channels. The high affinity channel has been previously
reported, as in the present study, to be sensitive to dilti-
azem and, therefore, to belong to a L-type, whereas the
low affinity channel is sensitive to x-conotoxin MVIIC,
which preferentially targets the P/Q type. We now report
the presence of another category of channels in the distal
nephron segment, which is aldosterone dependent, and
which is inhibited by mibefradil, the specific T-channel
inhibitor. This inhibition was observed only with high
concentrations of Ca2+. Therefore, the low affinity com-
ponent reflects the activity of at least two Ca2+ channels,
of P/Q- and T-types. The luminal membrane of the distal
nephron is a very complex structure that is the site of at
least three Ca2+ channels that are differently regulated
by a variety of hormones, including aldosterone.
CONCLUSION
These in vitro experiments showed that the incubation
of rabbit distal tubules with aldosterone enhances trans-
port of both Na+ and Ca2+ by the luminal membranes,
implicating a tyrosine kinase activity. Kinetics studies sug-
gest that at least two types of Ca2+ channels are influenced
by the hormone: a high affinity channel whose response
to aldosterone is inhibited by diltiazem (a L-type Ca2+
channel inhibitor), and a low affinity channel, whose re-
sponse is curtailed by mibefradil (a T-type Ca2+ channel
inhibitor). Because only the Vmax of both kinetics com-
ponents of Ca2+ uptake is affected, we conclude that al-
dosterone increases the number of channels present in
the membranes without influencing the affinity of these
channels for Ca2+.
The apparent discrepancy between some previous
Ca2+ clearance studies and the present data can be eas-
ily explained by the complex in vivo situation. It is likely
that in these former experiments, the direct enhancement
of Ca2+ transport by aldosterone was hidden by Na+ re-
tention, secondary volume expansion, and decrease in
proximal tubule reabsorption.
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